Publications
2007
Brixner DI, Horowicz-Mehler N, Stern LS, Doyle JJ, Dolgitser M, Hagan M. Contraceptive and Non-Contraceptive Benefits of the Levonorgestrel Intrauterine System (LNG-IUS) in a Vertically Integrated HMO (Henry Ford Health System). In: The 2007 International Society for Pharmacoeconomics and Outcomes Research 2007 May 19-23, 2007; Arlington, VA 2007.
Bukstein DA, Murphy KR, Katz LM, Ramachandran S, Doyle JJ, Stern LS. Outcomes Among a Young Population of Pediatric Asthma patients Using Controller Therapies: Results from a Retrospective Database Analysis. Pediatric Asthma, Allergy & Immunology 2007;20(4):211-21.
Casciano R, Doyle JJ, Kellner J, et al. Pharmacoeconomic Evaluation of Heard Immunity Conferred by Seven-Valent Pneumococcal Conjugate Vaccine (Prevnar) in Canada Based on Calgary Region Epidemiological Data In: The 2007 International Society for Pharmacoeconomics and Outcomes Research 2007 May 19-23, 2007; Arlington, VA 2007.
Chalfin DB, Trzeciak S, Likourezos A, Baumann BM, Dellinger P. Impact of delayed transfer of critically ill patients from the emergency department to the intensive care unit. Critical Care Medicine 2007;35(6).
Doyle JJ, Neugut AI, Jacobson JS, et al. Radiation Therapy, Cardiac Risk Factors, and Cardiac Toxicity in Early-Stage Breast Cancer Patients. Int J Radiation Oncology Biol Phys 2007;68(1):82-93.
Foster GR, Fried MW, Hadziyannis SJ, Messinger D, Freivogel K, Weiland O. Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirin. Scand J Gastroenterol. 2007;42(2):247-55.
Guo A, Doyle JJ, Stern LS, Chen Y, Etschmaier M. A Pre-Post Time in Motion Methodology to Examine Product Wastage Reduction: Pilot Results in Magnetic Resonance Contrast Media Pharmacy Bulk Pack In: The 2007 International Society for Pharmacoeconomics and Outcomes Research 2007 May 19-23, 2007; Arlington, VA 2007.
Hitchcock W, Mellon M, Memran M, Parasuraman B, Ramachandran S, Walzer S. Caregiver Preferences for Pediatric Asthma Treatment Delivery Systems. Advances in Therapy. November/December 2007 2007;24(6):1240 - 1253.
Janka HU, Hessel F, Mueller E. Economic analysis of the treatment with insulin glargine plus oral antidiabetics (BOT) compared to twice daily premixed insulin (CT) based on the LAPTOP trial. In: ISPOR 10th European Congress, Dublin, Ireland, October 20 - 23, 2007.
Janka HU, Hessel F, Walzer S, MŸller E. Insulin glargine added to therapy with oral antidiabetic agents improves glycemic control and reduces long-term complications in patients with type 2 diabetes - a simulation with the Diabetes Mellitus Model (DMM). International Journal of Clinical Pharmacology and Therapeutics. 2007; 45(12):623-630.
Kaunitz AM, Stern LS, Doyle JJ, Etschmaier MR. Use of Levonorgestrel - IUD in the treatment of Menorrhagia: Improving patient outcomes while reducing the need for surgical management. Managed Care Interface 2007;20(3):47-50.
Krone FA. Recent Healthcare Reforms in Germany and Implications for Outpatient Care. In: Health Economics 2007 Meeting, Informa Life Sciences, Brussels, Belgium, May 15 - 16, 2007.
Krone FA. Bedeutung von Health Technology Assessment und Versorgungsforschung für Medizintechnologien im Gesundheitsmarkt., Berlin, Germany, June 19, 2007. (Workshop)
Krone FA. DGPharMed-Workshop - Health Technology Assessment: Welche Konsequenzen für die strategische und operative Ausrichtung von Unternehmen können gezogen werden? Würzburg, Germany, November 30, 2007. (Workshop)
Mount Hood 4 Modeling Group. Computer modeling of diabetes and its complications: a report on the Fourth Mount. Hood Challenge Meeting. Diabetes Care. 2007;30(6):1638-46.
Mueller E, Huppertz E, Stridde E. Vergleich der deutschen und britischen Diabetes Leitlinien: Auftreten von Spätkomplikationen und daraus resultierende Kosten - Simulationen mit dem EAGLE-Modell. In: German Diabetes Society, 42nd Annual Meeting, Hamburg, Germany, May 16 - 19, 2007.
Mueller E. Key Issues and Principles of Pricing and Reimbursement for Medical Devices. In: The advanced, legal, regulatory and commercial guide to medical devices, C5 conference, Munich, Germany. February 26th - 27th, 2007.
Mueller E, Huppertz E, Stridde E. Comparing British and German diabetes guidance with respect to longterm outcomes and associated costs: Results from the EAGLE diabetes simulation model. In: ISPOR 10th European Congress, Dublin, Ireland, October 22, 2007.
Schwander B, Haller H. Eprosartan - Gesundheitsökonomische Betrachtung; Antihypertensive Schlaganfallprophylaxe und gesundheitsökonomische Aspekte. In: German Society for Internal Medicine; 113th Annual Meeting , Wiesbaden, Germany, April 14 - 18, 2007.
Schwander B, Lindgren P, Gradl B. The cost-effectiveness (cost-utility) of eprosartan in hypertensive patients with cerebrovascular disease in Belgium, Germany, Spain, UK, and Sweden. In: ISPOR 10th European Congress, Dublin, Ireland, October 22, 2007.
Shorr AF, Stern LS, Raut MK, et al. Outcomes of Transfusions in Critically Ill Patients on Prolonged Mechanical Ventilation In: The Society of Critical Care Medicine 36th Critical Care Congress; 2007 February 17-21; Orlando, Florida; 2007.
Stern LS, Dolgitser M. Use of Medication Coverage Methodology in Measurement of Patient Compliance with Pharmacotherapy. In: ACCP; 2007; 2007.
Stridde E, Bierwirth R, Huppertz E,. Mueller E. Entwicklung mikrovaskulärer Langzeitkomplikationen und der assoziierten Kosten bei Patienten mit Typ-2-Diabetes in der diabetologischen Schwerpunktpraxis: Ergebnisse einer 10-Jahres-Simulation der TEMPO¨-Patientenkohorte mit dem EAGLE-Diabetes-Modell unter Einbeziehung der KoDiM-Daten. In: German Diabetes Society, 42nd Annual Meeting, Hamburg, Germany, May 16 - 19, 2007.
Tsai J, Lee J, Williams K, et al. The Impact of Pharmacotherapy Compliance on Healthcare Charges in Patients with Primary Open-Angle Glaucoma. In: The 2007 International Society for Pharmacoeconomics and Outcomes Research; 2007 May 19-23, 2007; Arlington, VA 2007.
Walt JG, Chiang TH, Doyle JJ, Berenson KL. Cost of Standard Care Treatment in Patients with Progression of Primary Open Angle Glaucoma. In: 2007 International Society for Pharmacoeconomics and Outcomes Research 2007 May 19-23, 2007; Arlington, VA; 2007.
Walt JG, Chiang TH, Stern LS, Doyle JJ. End-Stage Glaucoma Low Vision Care Services. Visual Impairment Research 2007.
Walt JG, Chiang TH, Stern LS, Doyle JJ. Characterization of the Living Environments of End-Stage Glaucoma Patients and Use of Low-Vision Care Services: A Physician Survey Study. Visual Impairment Research 2007;9(1):23-31.